Article

Clinical Trial Digest: Findings from Recently Published Randomized Controlled Trials


 

Recommended Reading

Image of the Month
MDedge Neurology
Amyloid β-Lowering Agent Fails in Phase III : Patients who received 800 mg of the drug saw the same cognitive decline as patients taking placebo.
MDedge Neurology
Tau-Targeting Drug May Aid Memory in Mild Dementia
MDedge Neurology
Young-Onset Dementia Is Rarely Caused by Alzheimer's Disease
MDedge Neurology
Transcranial Direct Current Stimulation Helps Patients With Alzheimer's Disease and Aphasia
MDedge Neurology
Reviewing the Safety and Tolerability of Alzheimer's Disease Medications
MDedge Neurology
An Antihistamine for Alzheimer's Disease?
MDedge Neurology
Diagnostic Evaluations for Alzheimer's Disease and MCI
MDedge Neurology
Healthy Diet, Exercise, and Socialization May Protect Against Dementia
MDedge Neurology
Smoking in Midlife Might Increase Risk for Dementia
MDedge Neurology